From what I understand partly due to the 41 week covid interuption delay only 33 people started on the PDD OLE trial and 20 finished in so around 60% completion. If say 70% of the 191 dosed completers continued onto OLE then that would mean 134 from this group. If 60% of 122 placebo completers then 73 from this group. Would mean 207 at start of OLE so if the same 60% odd OLE completion would be around 124 at end of 96 week trial. Not amazing number number but enough to get some more confirmatory data. 60-70% completion would be roughly the expected completion from this type of trial. What was the change in wording from the 10k?
Market Data 
Markets 
